# Citicoline as Neuroprotector in Preterm

> **NCT03966170** · PHASE3 · RECRUITING · sponsor: **Sherief Abd-Elsalam** · enrollment: 40 (estimated)

## Conditions studied

- Pre-Term

## Interventions

- **DRUG:** Citicoline
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT03966170
- **Lead sponsor:** Sherief Abd-Elsalam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-01
- **Primary completion:** 2028-11
- **Final completion:** 2028-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03966170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03966170, "Citicoline as Neuroprotector in Preterm". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03966170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*